Gut modulatory and antiplatelet activities of Viscum cruciatum

References

• Alali FQ, Tawaha K, El-Elimat T, Syouf M, El-Fayad M, Abulaila K, Nielsen SJ, Wheaton WD, Falkinham JO, Oberlies NH (2007): Antioxidant activity and total phenolic content of aqueous and methanolic extracts of Jordanian plants: An ICBG project. Nat Prod Res 12: 1121–1131.
   Google Scholar
• Arunlakhshana O, Schild HO (1959): Some quantitative uses of drug antagonists. BrJ Pharmacol 14: 48–58.
   PubMed Web of Science ®Google Scholar
• Ayuso MJ, Martín-Cordero C, Sáenz MT (1988): Activité antimitotique de Viscum cruciatum Sieber parasite de Olea europaea subsp. Europaea et de Retama sphaerocarpa. Fitoterapia 59: 222–226.
   Google Scholar
• Bolton TB (1979): Mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev 59: 606–718.
   PubMed Web of Science ®Google Scholar
• Brown JH, Taylor P (1996): Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds., Goodman & Gillman’s the Pharmacological Basis of Therapeutics, 9th ed. New York, McGraw-Hill, pp. 141–159.
   Google Scholar
• Brunton LL (1996): Agents effecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds., Goodman & Gillman’s the Pharmacological Basis of Therapeutics, 9th ed. New York, McGraw-Hill, pp. 917–936.
   Google Scholar
• Carmen MC, Miguel LL, María AA, Eduardo N, Juan T, María JA (2001): A cytotoxic diarylheptanoid from Viscum cruciatum. Phytochemistry 58: 567–569.
   PubMedGoogle Scholar
• Duke JA (1992): Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants, 2nd ed. Boca Raton, CRC Press, p. 636.
   Google Scholar
• Edeoga HO, Okwu DE, Mbaebie BO (2005): Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotech 4: 685–688.
   Web of Science ®Google Scholar
• Evans WC (1996): Trease and Evan’s Pharmacognosy, 14th ed. London, WB Saunders, pp. 161–408.
   Google Scholar
• Farre AJ, Columbo M, Fort M, Gutierrez B (1991): Differential effects of various Ca++ antagonists. Gen Pharamacol 22: 177–181.
   PubMedGoogle Scholar
• Fleckenstein A (1977): Specific pharmacology of Ca++ in myocardium cardiac pacemakers and vascular smooth muscle. Rev Pharmacol Toxicol 17: 149–166.
   PubMed Web of Science ®Google Scholar
• Ghayur MN, Gilani AH (2005): Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci 50: 1889–1897.
   PubMed Web of Science ®Google Scholar
• Gilani AH, Aftab K (1992): Presence of acetylcholine-like substance(s) in Sesamum indicum. Arch Pharmacal Res 14: 3–6.
   Google Scholar
• Gilani AH, Aftab K, Ahmed S(1994): Cholinergic actions of crude saponins from Castanospermum australe. Int J Pharmacog 32: 209–216.
   Google Scholar
• Gilani AH, Aziz N, Ahmed M, Alam MT, Riawani GH (1999): Spasmogenic and spasmolytic constituents in Sida pkistanica. Pharm Biol 37: 173–180.
   Google Scholar
• Gilani AH, Aziz N, Khurram IM, Rao ZA, Ali BA (2000): The presence of cholinomimetic and calcium antagonist constituents in Piper betle Linn. Phytother Res 14: 338–344.
   Google Scholar
• Gilani AH, Shah AJ, Ghayur MN, Majeed K (2005): Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 76: 3089–3105.
   PubMed Web of Science ®Google Scholar
• Gilani AH, Khan A, Ghayur MN (2006): Presence of calcium antagonist and cholinomimetic constituents explains the medicinal uses of olives in gastrointestinal disorders. Nutr Res 26: 277–283.
   Web of Science ®Google Scholar
• Godfraind T, Miller R, Wibo M (1986): Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321–416.
   PubMed Web of Science ®Google Scholar
• Haas K, Bauer M, Wollenweber E (2003): Cuticular waxes and flavonol aglycones of mistletoes. Z Naturforsch (7–8): 464–470.
   Google Scholar
• Karaki H, Wiess G (1983): Mini-review: calcium release in smooth muscles. Life Sci 42: 111–112.
   Web of Science ®Google Scholar
• Kimura Y, Okuda H (1994): Effects of alpha and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets. Biochem Biophys Res Commun 202: 1069–1075.
   PubMedGoogle Scholar
• Mohammed S, Ali S, Zohara Y, Jamal M (2000): Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J Ethnopharmacol 73: 221–232.
   PubMedGoogle Scholar
• Nadkarni KM (1976): Indian Materia Medica, 3rd ed. Bombay, Popular Prakashan, pp. 560–561.
   Google Scholar
• National Research Council (1996): Guide for the Care and Use of Laboratory Animals. Washington, National Academy Press, pp. 1–7.
   Google Scholar
• Oury C, Toth ZE, Vermylen J, Hoylaerts MF (2006): The platelet ATP and ADP receptors. Curr Pharm Des 12: 859–875.
   PubMed Web of Science ®Google Scholar
• Revuelta MP, Cantabrana B, Hidalgo A (1997): Depolarization-dependent effect of flavonoids in rat uterine smooth muscle contraction elicited by CaCl2. Gen Pharmacol 29: 847–857.
   PubMedGoogle Scholar
• Saeed SA, Shah BH, Khan N, Gilani AH (1997): Synergistic interaction of calcium-ionophore, A-23187 and dopamine in human platelet aggregation. Med Sci Res 25: 219–221.
   Google Scholar
• Salam SR, Saxena R, Saraya AK (1991): Effect of calcium channel blocker (diltiazem) on platelet aggregation. Indian J Exp Biol 29: 484–485.
   PubMedGoogle Scholar
• Shah BH, Saeed SA (1995): Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine. Res Commun Mol Pathol Pharmacol 89: 157–164.
   PubMedGoogle Scholar
• Triggle DJ (1992): Drugs affecting calcium-regulation and actions. In: Smith GM, Reynard AM, eds., Textbook of Pharmacology. Philadelphia, WB Saunders Co., pp. 453–479.
   Google Scholar
• Van Rossum JM (1963): Cumulative concentration-response curves. II. Techniques for the making of concentration-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143: 299–330.
   PubMedGoogle Scholar
• Williamson EM, Okpako DT, Evans FJ (1996): Selection, Preparation and Pharmacological Evaluation of Plant Material. Chichester, John Wiley & Sons, pp. 15–23.
   Google Scholar